A benzodiazepine antagonist does not alter the course of hepatic encephalopathy or neural ?-aminobutyric acid (GABA) binding
Data up to Jan 2025
Total Citations Per Year
Abstract
References (10)
Advances in hepatic encephalopathy and urea cycle diseases
1985 • 146 citations
Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure
1987 • 144 citations
Experimental Hepatic Encephalopathy: Changes in the Binding of γ-Aminobutyric Acid
1982 • 126 citations
Supersensitivity of Benzodiazepine Receptors in Hepatic Encephalopathy Due to Fulminant Hepatic Failure in the Rat: Reversal by a Benzodiazepine Antagonist
1984 • 125 citations
Gamma-aminobutyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure.
1983 • 107 citations
Changes in the Status of Neurotransmitter Receptors in a Rabbit Model of Hepatic Encephalopathy
1984 • 77 citations
Brain γ-aminobutyric acid receptor binding is normal in rats with thioacetamide-induced hepatic encephalopathy despite elevated plasma γ-aminobutyric acid-like activity
1987 • 75 citations
In vivo studies of GABAergic effects in experimental hepatic encephalopathy
1986 • 21 citations
Toxins in Hepatic Encephalopathy: The Role of the Synergistic Effect of Ammonia, Mercaptans and Short Chain Fatty Acids
1984 • 20 citations
Postsynaptic ?-aminobutyric acid receptors in hepatic coma following portacaval shunt and hepatic artery ligation in the rat
1987 • 12 citations